Methyl lucidenate D

Overview

Methyl lucidenate D is a selective inhibitor of Epstein-Barr virus early antigen ( EBV-EA ) activation with an IC 50 of 290 mol ratio/32 pmol TPA. Methyl lucidenate D exerts potential anti-tumor promoting activity by inhibiting TPA-induced EBV-EA activation and maintains major Raji cell survival (70%) at effective concentrations. Methyl lucidenate D can be used in the field of cancer chemoprevention.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > EBV

Product Information

• Catalog No.: HY-N13723
• CAS No.: 98665-09-9
• Molecular Formula: C30H40O8
• Molecular Weight: 528.63
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source